Compounds that Modulate EGFR Activity and Methods for Treating or Preventing Conditions Therewith
                        
                            
                                申请人:Gatekeeper Pharmaceuticals, Inc.
                            
                            
                                公开号:US20160137610A1
                            
                            
                                公开(公告)日:2016-05-19
                            
                            Provided are compounds and methods for treating or preventing kinase-mediated disorders therewith.
                            提供了化合物和方法,用于治疗或预防由激酶介导的疾病。